1
/
of
0
FDA Drug Approval, N018421, LITHIUM CITRATE
FDA Drug Approval, N018421, LITHIUM CITRATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018421
Company: HIKMA
Drug Name: LITHIUM CITRATE
Active Ingredients: LITHIUM CITRATE
Strength: EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SYRUP;ORAL
Action Date: 12/23/1980
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: HIKMA
Drug Name: LITHIUM CITRATE
Active Ingredients: LITHIUM CITRATE
Strength: EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SYRUP;ORAL
Action Date: 12/23/1980
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details